Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Journal of Mass Spectrometry and Advances in the Clinical Lab is Scopus-indexed (Q1, CiteScore 6.3), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by Elsevier B.V..
Checked against the index lists dated .
ISSN 2667-145XVerify ISSN ↗2667-1468Verify ISSN ↗
Publisher: Elsevier B.V.
Cost to publish: About US$900 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Medical Laboratory Technology | 7 / 42 | 84th | Q1 |
| Spectroscopy | 19 / 81 | 77th | Q1 |
| Clinical Biochemistry | 39 / 124 | 68th | Q2 |
| Microbiology | 70 / 194 | 64th | Q2 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2021–2025, best quartile Q1, CiteScore 6.3.
Journal of Mass Spectrometry and Advances in the Clinical Lab is Q1 in Medical Laboratory Technology (rank 7 of 42), Q1 in Spectroscopy (rank 19 of 81) and Q2 in Clinical Biochemistry (rank 39 of 124), by CiteScore 2025. It is ranked in 4 subject areas in all.
Journal of Mass Spectrometry and Advances in the Clinical Lab is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 6.3, which places it in quartile Q1 at the 84th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.743, quartile Q1, with an H-index of 23.
The publisher lists an article processing charge of about US$900 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Journal of Mass Spectrometry and Advances in the Clinical Lab is published by Elsevier B.V. Its print ISSN is 2667-145X and its online ISSN is 2667-1468.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Journal of Mass Spectrometry and Advances in the Clinical Lab has an h-index of 24 and a 2-year mean of 3.71 citations per paper (OpenAlex). Its Scopus CiteScore is 6.3, quartile Q1. On 2-year citations it ranks #4 of 42 Scopus journals in Medical Laboratory Technology.
Journal of Mass Spectrometry and Advances in the Clinical Lab published 34 papers in 2025; its busiest recent year was 2022 with 44. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 96 research articles (2023–2026), authors are most often from United States (47.9%), China (8.3%) and Germany (8.3%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.